Research Database

15 studies found

Positive

40.0%

Negative

46.7%

Inconclusive

13.3%

Page 1 of 1

PositiveReview/Other

The effect of tilmicosin and diclofenac sodium combination on cardiac biomarkers in sheep

2023

Veterinary ApplicationsCardiac ToxicityCardiovascular Diseases (CVD)+1

InconclusiveMeta-analysis -

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

2023

Addiction - Cannabis

NegativeReview/Other

Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes

2022

Cannabis Adverse Effects

InconclusiveReview/Other

Cannabis and the heart: unchartered territory

2022

Atherosclerosis

PositiveAnimal Study -

C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice

2022

Cardiac Toxicity

NegativeReview/Other

Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use

2021

Addiction - Cannabis

NegativeAnimal Study - Veterinary Clinical Trial

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

2021

Poisoning by Synthetic Cannabis

NegativeReview/Other

Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report

2020

Cannabis Adverse Effects

NegativeReview/Other

Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report

2020

Cardiovascular Diseases (CVD)

NegativeAnimal Study - Veterinary Clinical Trial

Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption

2019

Addiction

NegativeReview/Other

Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

2018

Cardiac Toxicity

PositiveReview/Other

Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

2015

Anxiety

PositiveReview/Other

K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

2015

Cannabis Adverse Effects

PositiveReview/Other

Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

2015

Cardiac Toxicity

PositiveReview/Other

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity

2007

Cardiac Toxicity

Command Palette

Research Database

The effect of tilmicosin and diclofenac sodium combination on cardiac biomarkers in sheep

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes

Cannabis and the heart: unchartered territory

C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice

Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use

Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report

Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report

Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption

Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity